Literature DB >> 4959664

Candida in the faeces of children receiving oral tetracycline and phenoxymethyl penicillin.

R J Holt, R L Newman.   

Abstract

The faeces from 100 children under 14 years receiving no antibiotic or steroid therapy were examined for Candida spp. The proportion (8%) of positive isolates is compared with the number of Candida spp. isolated from the faces of 50 children receiving oral tetracycline (14%) and 59 children on phenoxymethyl penicillin (10%) for complaints other than gastrointestinal infections. The use of selective media is described and the significance of the greatly increased numbers of Candida spp. found by these methods is discussed. In this series no clinical manifestations of candidiasis were observed, although slightly more Candida spp. were recovered from the two groups of children on oral antibiotics than from those not on such therapy. It is suggested that, in children at least, there is a need to re-assess the significance of the presence of Candida in the bowel during the administration of oral antibiotics. The almost complete absence of active tetracycline from the faeces and the small proportion of tetracycline-sensitive bowl organisms, coupled with the low incidence of change in bowel flora in these patients, suggest that this is not the reason for proliferation of Candida in the cases that do occasionally occur.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4959664      PMCID: PMC473425          DOI: 10.1136/jcp.20.1.80

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

1.  Identification of Canda albicans in primary culture.

Authors:  C O DAWSON
Journal:  Sabouraudia       Date:  1962-02

2.  Rapid identification of Candida albicans by filamentation on serum and serum substitutes.

Authors:  C L TASCHDJIAN; J J BURCHALL; P J KOZINN
Journal:  AMA J Dis Child       Date:  1960-02

3.  Infections occurring during chemotherapy; a study of their frequency, type and predisposing factors.

Authors:  L WEINSTEIN; M GOLDFIELD
Journal:  N Engl J Med       Date:  1954-08-12       Impact factor: 91.245

4.  The growth of Candida albicans during antibiotic therapy.

Authors:  J L SHARP
Journal:  Lancet       Date:  1954-02-20       Impact factor: 79.321

5.  Effect of Nystatin on Growth of Candida albicans During Antibiotic Therapy.

Authors:  A J Childs
Journal:  Br Med J       Date:  1956-03-24

6.  Laboratory and Clinical Studies with Nystatin in Post-antibiotic Mycotic Infections.

Authors:  G T Stewart
Journal:  Br Med J       Date:  1956-03-24

7.  Incidence of candida in hospital in-patients and the effects of antibiotic therapy.

Authors:  B J Smits; A P Prior; P G Arblaster
Journal:  Br Med J       Date:  1966-01-22
  8 in total
  4 in total

1.  Epidemiological investigations or oral Candida albicans.

Authors:  J A Schmitt
Journal:  Mycopathol Mycol Appl       Date:  1971-01-25

2.  Incidence of yeasts and influence of nystatin on their control in a group of burned children.

Authors:  R F Smith; S L Dayton; D Blasi; D D Chipps
Journal:  Mycopathologia       Date:  1975-04-30       Impact factor: 2.574

3.  Laboratory assessment of the antimycotic drug clotrimazole.

Authors:  R J Holt; R L Newman
Journal:  J Clin Pathol       Date:  1972-12       Impact factor: 3.411

4.  The antimycotic activity of 5-fluorocytosine.

Authors:  R J Holt; R L Newman
Journal:  J Clin Pathol       Date:  1973-03       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.